Additionally, the anti-tumor properties of NK cells return upon the activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant pathway, thus overriding the negative impacts of STAT3 activation on the immune cells [59]. The gene discussed is STAT3; the disease is neoplasm.